跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
TUBERSOL tuberculin purified protein derivative (mantoux) diagnostic antigen vial
Approved
STANDARD
TUBERSOL tuberculin purified protein derivative (mantoux) diagnostic antigen vial
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6ae8ae62b7e1e806
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6ae8ae62b7e1e806
Product Name
TUBERSOL tuberculin purified protein derivative (mantoux) diagnostic antigen vial
Artg Id
28624
Artg Name
TUBERSOL tuberculin purified protein derivative (mantoux) diagnostic antigen vial
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
1991-11-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6ae8ae62b7e1e806
Type
Standard
Back to TGA Approvals
TUBERSOL tuberculin purified protein derivative (mantoux) diagnostic antigen vial - TGA Drug Approval Details